- This qualitative study used TAM-guided individual interviews with 35 participants: 11 children, 12 family caregivers, and 12 medical staff, analyzed by thematic analysis.
- No intervention was tested; the study explored stakeholder perceptions, needs, and barriers regarding AI-based pain assessment in pediatric care.
- All groups saw AI's core value as objective, continuous monitoring, but priorities diverged: staff sought decision support, caregivers wanted real-time information, and children wanted communication and emotional support.
- Stakeholders agreed AI should aid rather than replace clinical judgment, and adoption hinges on proven accuracy, workflow compatibility, safety, and trust.
Chronic pain
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- Prospective point-prevalence study of 19,438 hospitalised adults from 180 hospitals in 22 African nations, conducted September to December 2023.
- Worst pain in the preceding 24 hours was rated on a 0 to 10 scale, and critical illness was defined as at least one out-of-range vital sign.
- Acute pain prevalence was 67.9%, and 2795 patients (14.4%) reported severe pain of 7/10 or higher.
- Higher pain severity was associated with greater 7-day mortality, but not with critical illness, and the authors frame the burden as comparable to high-income countries.
- This preclinical study used virtual screening and cell and mouse models to identify and test P06, a small-molecule GPR37L1 agonist, for neuropathic pain.
- A single intrathecal P06 injection was compared with vehicle in chemotherapy-induced and spared nerve injury models, including Gpr37l1 knockout mice.
- P06 produced inhibition of chemotherapy-induced mechanical allodynia lasting more than 24 hours, and this effect was abolished in knockout mice.
- P06 also reduced spared nerve injury allodynia and dorsal root ganglion gliosis, and acted directly on glia to suppress paclitaxel-induced IL-1β release.
- Controlled in vivo study in male mice combining patch-clamp electrophysiology with a complete Freund's adjuvant model of persistent inflammatory pain.
- Chemogenetic inhibition of nucleus accumbens VGluT2 neurons was tested for effects on paw withdrawal, withdrawal latency, and anxiety-like behavior in the open field and elevated plus maze.
- Over 90% of these non-GABAergic neurons showed intrinsic burst firing, and they became hyperexcitable under inflammatory pain conditions.
- Inhibiting them alleviated pain hypersensitivity and bidirectionally modulated pain-related anxiety-like behavior, which the authors propose as a precise target for persistent pain.
- This preclinical study used unrestrained mice with an intracranial nerve-compression model of trigeminal neuralgia (FRICT-ION) to assess facial pain behaviors.
- Investigators used high-frame-rate videography and DeepLabCut tracking to quantify spontaneous asymmetric grooming, evoked facial rubbing, and head movement speed after facial stimulation.
- Injury-related behavioral changes were reversed by a nonsedating carbamazepine dose, and head movement speed after stimulation was identified as a carbamazepine-sensitive correlate of allodynia.
- The authors conclude these measures reproduced the clinical successes and failures of several nonopioid analgesics, which they expect will aid development of new trigeminal neuralgia therapies.
- This is a narrative review of open-label placebo (OLP) research in pain, with no new study population or sample size.
- It covers open-label placebos, where inert treatments are given transparently, and sets out guidance on control groups, blinding strategies, and reporting standards.
- The review reports no quantitative results; it highlights methodological challenges of unblinded designs and draws on patient advisory board input on feasibility and acceptability.
- The authors conclude that patient-centered design choices may improve the quality, relevance, and clinical translation of OLP research in pain.
- This is a commentary, not an empirical study, drawing on recent calls to action in paediatric pain and youth mental health.
- An international, transdisciplinary and cross-sectoral group, including a young lived-experience partner, co-created transformation targets for young people with both conditions.
- The authors argue that co-occurring chronic pain and mental health conditions add a cumulative burden beyond either alone, yet siloed care leaves young people passed between services.
- They propose practical actions under three themes: connected needs, connected care and connected systems, aimed at person-centred, equitable care.
- This single-patient case report describes an elderly osteoporotic woman with atraumatic low back and groin pain and MRI-confirmed bilateral sacral insufficiency fractures.
- She underwent CT-guided bilateral sacroplasty after four weeks of failed conservative care for persistent axial pain.
- Immediate severe right L5-S1 radicular pain followed, with imaging showing cement extravasation into the right S1 foramen, epidural space, and sacral canal.
- Pharmacologic treatment, rehabilitation, and one right L5 and S1 transforaminal epidural steroid injection led to gradual resolution, so surgery was deferred; the authors support nonoperative care in selected patients without deficits.
- Systematic review and meta-analysis of 11 randomized controlled trials (n = 810) testing exercise for pregnancy-related pelvic girdle pain.
- The review explored how exercise prescription parameters, such as supervision and core-focused programs, related to pain and function outcomes.
- Exercise significantly reduced pain (SMD -0.81; 95% CI -1.06 to -0.55) and improved function (SMD -0.69; 95% CI -1.01 to -0.37), with moderate certainty.
- Limited subgroup data suggested supervised abdominopelvic core exercise may have larger effects, but these findings had substantial heterogeneity and very low to moderate certainty.
- This systematic review and meta-analysis pooled 21 studies (3 randomized trials) with 605 ketamine-treated CRPS patients, mostly at moderate to high risk of bias.
- Pain change was pooled from the earliest post-infusion assessment within 14 days, with scores rescaled to 0-10 against a pooled baseline of 7.4.
- The mean pain change was -3.6 (95% CI -4.7 to -2.5) within 14 days, and longer-term data up to 90 days suggested a gradual return toward baseline.
- Median responder rate was 65% (range 0-100%), but only 3 studies formally assessed predictors; sympathetically maintained pain (aOR 6.54) and obesity (aOR 8.75) had wide CIs.
- This perspective article is a position paper with no original patient data, arguing about how pain diagnosis is framed.
- It contrasts the structural paradigm, which equates disease with visible imaging or lab abnormality, with nociceptive mechanisms spanning peripheral, spinal, and supraspinal levels.
- It cites mechanistic studies reporting microstructural, neuroimmune, electrophysiological, and metabolic abnormalities in chronic pain patients whose imaging and labs appear normal.
- The authors call for diagnostics realigned with nociceptive physiology and for emerging imaging tools that detect pathology invisible to conventional structural imaging.
- This Fact Finders series reviews evidence on epidural preservative-containing steroids and swabbing newly opened vial tops before drawing up injectate.
- It reports no documented adverse events from epidural preservative-containing steroids, though neurological injuries have been reported after intrathecal injection of these preservatives.
- Evidence for vial-top swabbing is mixed: a recent study found no significant benefit, yet ASA, CDC, and WHO guidelines still recommend it.
- The authors also note that isopropyl alcohol above 60% is not universally effective against all pathogens.
- Systematic review and multivariate meta-analysis of 118 studies (N = 11,822) comparing adults with fibromyalgia, knee osteoarthritis, low back pain, or neck pain against pain-free controls.
- Case-control differences were pooled as Hedges' g across five domains: brain, sensory, psychological, motor, and tissue measures.
- Psychological (g = 1.08, 95% CI 0.94-1.22) and sensory (g = 0.85, 95% CI 0.61-1.08) differences were larger than motor, brain, and tissue differences, with tissue smallest (g = 0.30, 95% CI 0.05-0.55).
- Effect patterns differed by diagnosis, with fibromyalgia showing larger differences across domains; the authors suggest multidomain assessment may help distinguish pain states.
- Preclinical study in male and female Long Evans rats given intermittent ethanol or air during the peri-adolescent period, with mechanical and thermal sensitivity tested weekly during 4 weeks of abstinence.
- Ethanol exposure was compared with air exposure, and adolescent ethanol was reported to augment mechanical sensitivity in both sexes.
- Air-exposed females were more sensitive than males at baseline, and thermal sensitivity changes appeared only in male rats after ethanol exposure.
- Ethanol did not alter fear conditioning at week 6, so the pain sensitivity changes did not generalize to fear responses, according to the authors.
- Single-arm feasibility trial of 110 youth aged 10-18 with chronic pain who enrolled from 236 referrals at a tertiary pain clinic.
- A single-session Empowered Relief for Youth class, adapted from an adult program, teaches pain science and self-regulatory skills, with no comparator group.
- Over 80% rated the class credible, acceptable, and feasible, and pain interference, catastrophizing, and anxiety improved from baseline to 1 month and held through 3 months.
- An exploratory analysis linked greater pain interference improvement at 3 months to attending within 30 days of the clinic evaluation, which the authors call promising.
- Multicentre cohort of 604 CRPS patients (520 type I, 84 type II) who underwent DFNS quantitative sensory testing, using 13 parameters.
- Unsupervised, hypothesis-free cluster analysis was run on a training set (n=380) and checked in a validation set (n=224), rather than using predefined mechanistic subtypes.
- Three sensory phenotypes emerged: hypersensitivity to cold and heat pain (n=382), loss of thermal and mechanical sensation (n=200), and strong allodynia with mechanical hyperalgesia (n=22).
- The authors propose a bottom-up sensory stratification of CRPS that adds to mechanistic understanding when compared with human pain surrogate models.
- A multicenter prospective study followed 20 participants with cervicogenic headache or occipital neuralgia, excluding migraine, through 12 months.
- Bilateral percutaneous occipital nerve leads were left in place for up to 60 days and then withdrawn; no comparator group is described.
- 82% of participants reported sustained reductions of at least 50% in pain and/or pain interference through 12 months.
- Secondary measures, including neck disability and quality of life, also showed clinically meaningful change, and no new device-related adverse events occurred after 3 months.
- Secondary analysis of baseline data from 643 maintenance hemodialysis patients with chronic pain enrolled in the HOPE Consortium trial.
- Latent profile analysis identified five symptom clusters, and social determinants of health were examined as predictors of cluster membership.
- Higher everyday discrimination was linked to higher odds of moderate-anxiety and high-all-symptoms clusters, relative to the average-symptom cluster; no effect sizes or CIs are reported in the abstract.
- Greater residential segregation was associated with higher odds of the low-anxiety cluster, and greater income inequality with the moderate-anxiety cluster; the authors call for multi-level interventions.
- A data-driven simulation study built on FDA-submitted bunionectomy trials compared single-imputation rescue methods with a new reference-based approach.
- Single-imputation methods (LOCF, BOCF, WOCF) were compared with MIRA, which uses historical analgesic efficacy data to adjust pain scores after rescue medication.
- Treatment effects on the sum of pain intensity differences were overestimated by 6% to 7% with LOCF and 31% to 34% with WOCF, and underestimated by 2% to 14% with BOCF.
- MIRA gave approximately unbiased estimates under correct specification, stayed robust to rescue-effect misspecification up to 50%, and was corroborated in 3 independent bunionectomy trial reanalyses.
- Retrospective single-institution cohort of 134 adults who had basivertebral nerve ablation, grouped by Modic change subtype on pre-procedure MRI (Type 1 n=59, Type 2 n=52, Mixed n=23).
- Exposure is the Modic subtype, with pain tracked by VAS at baseline, 4-6 weeks, 6 months and 12 months after ablation; there was no separate comparator arm.
- VAS fell significantly at 12 months in every group: Type 1 from 7.44 to 3.15, Type 2 from 7.12 to 3.29, and Mixed from 5.87 to 2.00 (all p<0.001).
- The authors report that 81.3% reached a ≥2-point VAS decrease at 12 months with no difference between subtypes, concluding outcomes were comparable across Modic subtypes.
- Retrospective single-center chart review of 358 patients considered for an SCS trial between 2013 and 2023.
- Impediments to trial progression were classified from electronic health records, and demographic variables were analyzed with logistic regression.
- 84 patients (23.5%) did not progress; medical reasons (39.8%) were the most common impediment, followed by patient-directed decisions (25.8%).
- CRPS was the only demographic variable significantly associated with non-progression (b = -0.82, p = 0.04), and the authors report 20.7% did not progress for reasons unrelated to MRI.
- In mice, large-scale in vivo calcium imaging of lumbar DRG neurons after spared-nerve injury examined both spontaneous and stimulus-evoked activity.
- Spared-nerve injury increased the incidence of single-neuron spontaneous activity, and retrograde labeling separated injured from spared afferents.
- Spontaneous activity arose from injured afferents (51.8%) and spared neurons (48.2%), and 48.4% of spontaneously active spared neurons had no detected evoked responses.
- Spontaneous activity incidence correlated with spontaneous pain-like behavior but not mechanical hypersensitivity, which the authors read as support for a direct link to spontaneous pain.
- A case report of one 65-year-old woman with diabetes and prior L4-S1 posterior stabilization who received an ultrasound-guided caudal epidural steroid injection.
- After initial relief, she developed malaise and injection-site burning on post-procedure day three, with elevated acute-phase reactants on labs.
- Contrast-enhanced MRI suggested sacrococcygeal osteomyelitis at S4-S5 and Co1 with cellulitis, and she improved with empirical IV antibiotics after infectious diseases consultation.
- The authors present this as a rare but serious CESI complication, citing diabetes and prior spinal instrumentation as risk factors and stressing early recognition of new or worsening post-procedure pain.
- Single-patient case study of a 43-year-old man with small fiber neuropathy and the TRPA1 H560D variant, with patient-derived sensory-like neurons and HEK293 cell models.
- Compared TRPA1 H560D with wild-type TRPA1 using calcium flux, calcium imaging, and patch-clamp under agonist and antagonist conditions.
- H560D showed reduced sensitivity to allyl isothiocyanate in sensory-like neurons (P < 0.001) and transfected HEK293 cells (P < 0.05), with smaller agonist-evoked currents (P < 0.05).
- The variant also reduced TRPA1 expression (P < 0.001), impaired membrane localization and glycosylation, and the authors frame it as loss-of-function despite the patient's pain.
- Prospective study of 50 patients from a tertiary physiatry clinic with persistent upper cervical pain after negative C2-C3 and C3-C4 work-up, enrolled 2022–2025.
- All underwent fluoroscopy-guided lateral C1-C2 intra-articular injection with lidocaine and dexamethasone, with immediate and 3-month response assessed.
- At 30 minutes, 22/49 (44.9%) responded to the diagnostic block; at 3 months, 16/48 (33.3%) met responder criteria.
- Facial pain predicted lower odds of immediate response while neck-predominant pain predicted higher odds; response at T0 did not predict 3-month response, so diagnostic and therapeutic phenotypes may differ.
- Prospective longitudinal sample of 4,645 U.S. Army service members assessed before and at three timepoints after combat deployment, plus a separate cross-sectional sample of 6,333 at about 6 years post-enlistment.
- Exposures examined were combat injury, post-deployment pain, pain intensity, interference and catastrophizing, and perceived burdensomeness and acquired capability, with past-30-day suicidal ideation as the outcome.
- Combat injury was not prospectively associated with suicidal ideation at 3 or 9 months post-deployment, whereas pain interference (OR=1.60, 95% CI 1.13-2.27) and catastrophizing (OR=1.57, 95% CI 1.04-2.38) at 3 months predicted suicidal ideation at 9 months.
- In the cross-sectional sample, pain interference was associated with suicidal ideation (OR=2.21, 95% CI 1.63-3.01) but combat-injury-related pain was not, and the pain interference association persisted after adjusting for burdensomeness and acquired capability.
- In mice, the authors traced a recurrent excitatory loop from hindlimb primary somatosensory cortex to a subset of ventral posterolateral thalamic neurons and back to cortex.
- Optogenetic and chemogenetic activation of this loop lowered mechanical withdrawal thresholds at baseline, while inhibiting it reduced allodynia and spontaneous pain in the spared nerve injury model.
- Fiber photometry showed the pathway amplified cortical responses to normally subthreshold mechanical stimuli, which the authors interpret as sensory amplification.
- The authors conclude that this pathway becomes pathologically engaged in neuropathic pain and may be a selective excitatory target for intervention.
- This is a perspective article, not an empirical study, discussing group RCT challenges in low- and middle-income settings for clinical pain research.
- It proposes single-case experimental designs as a complementary approach, tracking individuals across different conditions over time.
- The abstract reports no quantitative results; its claims are that these designs need small samples and can include more diverse participants.
- The authors conclude that single-case designs may be resource-efficient and pragmatic, potentially supporting more clinical trials in these settings.
- Randomized experiment in 81 pain-free participants assigned to social support, social safety, or social threat picture cues during an operant robotic-arm pain-avoidance task.
- Social support cues (a picture of a supportive figure) were compared with sex-matched smiling-stranger safety cues and angry-stranger threat cues.
- Avoidance learning was successfully acquired, but the three groups did not differ on any outcome, including self-reported pain-expectancy, pain-related fear, or fear-potentiated startle.
- The authors conclude that social support cues do not modulate operant pain-avoidance, self-reported fear, or pain-expectancy, unlike arousal-based fear measures.
AI summary not available. Read the source abstract on PubMed.
- Preclinical study in male and female mice with chronic constriction injury of the sciatic nerve, combining behavioral, electrophysiological, immunohistochemical, and molecular assays.
- Systemic ISO-1, a small-molecule MIF inhibitor, was tested against the injury model, with outcomes examined in spinal dorsal horn slices, nerve injury site, and dorsal root ganglia.
- ISO-1 largely prevented the injury-induced excitatory-inhibitory postsynaptic current imbalance and significantly reduced macrophage infiltration, but relieved allodynia and hyperalgesia only in males.
- The authors position MIF targeting as a promising strategy and emphasize that sex-specific responses should inform future personalized immunomodulatory therapies.
- Nationwide retrospective cohort of 3,437,021 South Korean adults who underwent national health screening in 2012 and were followed through 2022, using national insurance claims data.
- Income level, cumulative low- or high-income duration, income change, and income volatility over the prior 5 years were examined as exposures for incident CRPS, identified by diagnostic codes plus rare intractable disease registration.
- The lowest income quartile had higher CRPS risk than the highest (aHR 3.74; 95% CI 3.07-4.56), with risk rising for longer low-income duration (aHR 1.91; 95% CI 1.48-2.45 at 5 vs 0 years).
- Longer high-income duration was linked to lower risk (aHR 0.55; 95% CI 0.44-0.70), and high income volatility and downward income change were also independently associated with higher risk, which the authors interpret as socioeconomic vulnerability.
- Retrospective cross-sectional study of active-duty service members in the US Military Health System, 2016–2021, with at least 24 months of continuous eligibility.
- Exposures were facility- and clinician-level characteristics at the index visit; outcomes were any nonpharmacological treatment and NPT before pharmacological treatment within 60 days.
- Forty percent received NPT within 60 days, rising from 39% in 2016 to 46% in 2021, and facility NPT personnel availability was associated with both outcomes.
- A physical therapist availability 1 SD above the mean corresponded to a 0.5% higher adjusted probability of each outcome; the authors suggest clinician availability as a modifiable barrier.
- This secondary analysis of the WELBack RCT included 372 adults with chronic non-specific low back pain, with outcomes collected at baseline and 2 months.
- The 9-item PROMIS-29-derived Impact score was compared against legacy measures, including the Oswestry Disability Index, NRS pain, EQ-5D-5L, PSFS, and GPE.
- Convergent validity met 80% of predefined hypotheses, responsiveness had an effect size of 0.8, and the criterion-based AUC was 0.73.
- The authors estimated a minimal clinically important difference of 6 points using the GPE as an anchor and concluded the score is valid and acceptably responsive.
- Preclinical study in mice using sciatic nerve chronic constriction injury, comparing wild-type, CX3CR1 knockout, and CX3CL1-transgenic animals.
- Nerve injury activated microglia and macrophages and reduced downstream TGF-β family protein expression as full-length CX3CL1 was cleaved and consumed.
- Losing CX3CR1 worsened neuroinflammation, while CX3CL1 overexpression enhanced TGF-β/Smad2/3 signaling, lowered proinflammatory cytokines, and alleviated hyperalgesia.
- The authors conclude that enhancing CX3CL1 signaling mitigates neuroinflammation and neuropathic pain-like behavior through CX3CR1-dependent and TGF-β-dependent pathways.
- This was a study of 231 pediatric patients with migraine-like or tension-type-like headache at a tertiary care center who met ICD-11 chronic primary pain criteria.
- The authors used grid search and ROC analyses to test data-informed changes to ICD-11 criteria for chronic primary headache, chronic tension-type headache, and chronic migraine.
- Aligning time criteria with chronic primary pain (at least 3 months, with no hours or days per month specified) gave the best approach for all three diagnoses.
- For chronic tension-type headache, allowing moderate nausea and up to 2 migraine-like symptoms gave the best sensitivity and specificity relative to migraine-like headache; the authors recommend adding pediatric coding notes to ICD-11.
- A cross-sectional nationwide survey of 1106 people with multiple sclerosis used the Michigan Body Map to identify chronic low back pain and self-reported disability and quality-of-life measures.
- The study compared people with and without chronic low back pain across disability, pain, mood, fatigue, cognition, sleep, and activity measures.
- 49.5% (95% CI 46.5%-52.4%) reported chronic low back pain, and greater disability was associated with higher odds of it (OR=1.21, 95% CI 1.02-1.44, p=0.02).
- Chronic low back pain was linked to higher pain intensity, pain interference, anxiety, depression, and fatigue, and to lower perceived cognition, but not to sleep, physical activity, or sedentary time.
- In 317 adolescents with juvenile fibromyalgia, enrolled in a randomized controlled trial, the authors compared one-week retrospective pain ratings with averaged daily diary ratings.
- Pain catastrophizing, functional disability, and depressive symptoms were tested as predictors of the gap between retrospective and daily diary pain reports across baseline, post-treatment, and 3-month follow-up.
- Retrospective pain reports were significantly higher than diary reports over time, but none of the three psychosocial factors significantly predicted the size of the discrepancy in the longitudinal regression.
- The authors suggest cognitive biases such as recency bias or threat interpretation may matter more than psychosocial factors, though they did not measure these directly.
- Genome-wide association study using All of Us data across six genetic ancestries, including 313,931 participants (64,894 cases, 249,037 controls).
- The cross-ancestral meta-analysis found one chromosome 3 locus reaching genome-wide significance (lead SNP rs3849410, p = 2.64E-08), and sex-stratified analyses identified additional loci.
- Chronic pain was genetically correlated with anxiety (rg = 0.72, p = 2.00E-46), body mass index (rg = 0.43), C-reactive protein, and generalized addiction risk.
- The authors conclude that chronic pain shares genetic effects with several psychiatric, physical, and immune health conditions.
- Longitudinal resting-state fMRI study of 46 subacute back pain patients and 27 healthy controls from the public OpenPain dataset, with patients grouped as recovered or chronic by pain scores.
- Used a voxel-wise dysconnectivity count with data-driven clustering to map whole-brain connectivity, rather than seed-based or predictive analyses.
- The chronic group showed greater dysconnectivity in emotion, pain-processing and attentional regions, while the recovery group showed deviations in sensorimotor, visual and cognitive control regions.
- The authors conclude that baseline whole-brain connectivity patterns differ between patients who recover and those who develop chronic pain.